© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

Teva has agreed to pay a whopping $1.2 billion to settle a US lawsuit claiming its subsidiary Cephalon paid to hold up generic competition to its narcolepsy therapy Provigil. In a statement ...

Cephalon and Ception Therapeutics have entered into an agreement that provides Cephalon with an option to purchase all outstanding capital stock of Ception. Ception's lead drug is reslizumab, a ...